info:eu-repo/semantics/article
Mechanisms involved in the contraceptive effects of ulipristal acetate
Fecha
2020-03Registro en:
Munuce, María José; Gómez Elías, Matías Daniel; Caille, Adriana María; Bahamondes, Luis; Cuasnicu, Patricia Sara; et al.; Mechanisms involved in the contraceptive effects of ulipristal acetate; BioScientifica; Reproduction; 159; 3; 3-2020; 139-149
1470-1626
CONICET Digital
CONICET
Autor
Munuce, María José
Gómez Elías, Matías Daniel
Caille, Adriana María
Bahamondes, Luis
Cuasnicu, Patricia Sara
Cohen, Débora J.
Resumen
The use of emergency contraception (EC) methods is increasing worldwide as it constitutes an effective way to prevent unplanned pregnancy after unprotected sexual intercourse. During the last decade, ulipristal acetate (UPA), a selective progesterone receptor modulator, has emerged as the most effective EC pill, and it is now recommended as first-line hormonal treatment for EC in several countries. Its principal mechanism of action involves inhibition or delay of follicular rupture, but only when administered during the follicular phase before the luteinizing hormone (LH) peak. However, considering the high efficacy of UPA, it is possible that it also exerts contraceptive effects besides ovulation. In the present review, we summarize and discuss the existing evidence obtained on the effect of UPA on sperm function and post-ovulatory events as potential additional mechanisms to prevent pregnancy. The bulk of evidence collected so far indicates that UPA would not affect gamete function; however, it could impair embryo?uterine interaction. Thus, besides the described effects on ovarian function, UPA contraceptive effectiveness might also be attributed to post-ovulatory effects, depending on the moment of the female cycle in which the drug is administered.